Neumora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	129.07	142.15	374.04	240.94	409.25	191.98
Short-Term Investments	42.45	165.43	79.94	130.94	-	-
Cash & Short-Term Investments	171.53	307.58	453.98	371.88	409.25	191.98
Cash Growth	-49.74%	-32.25%	22.08%	-9.13%	113.17%	-
Other Current Assets	5.56	6.48	24.3	16.07	6.36	1.86
Total Current Assets	177.08	314.06	478.28	387.96	415.6	193.84
Net Property, Plant & Equipment	0.55	2.92	6.86	10.64	4.04	3.92
Long-Term Investments	-	-	9.85	23.51	-	-
Other Long-Term Assets	0.2	-	1.21	4.13	9.65	0.18
Total Assets	177.83	316.97	496.2	426.23	429.3	197.95
Accounts Payable	0.55	3.31	0.34	7.15	1.64	2.4
Accrued Expenses	24.98	24.59	21.26	11.54	19.1	5.6
Current Portion of Leases	0.26	1.85	3.38	3.37	1.06	0.76
Other Current Liabilities	0.06	0.13	0.14	1.64	1.49	0.61
Total Current Liabilities	25.84	29.89	25.11	23.7	23.28	9.37
Long-Term Debt	19.56	-	-	-	-	-
Long-Term Leases	0.27	-	1.85	5.07	1	1.28
Other Long-Term Liabilities	-	0.02	0.16	0.63	0.39	-
Total Long-Term Liabilities	19.83	0.02	2.01	5.7	1.38	1.28
Total Liabilities	45.67	29.91	27.12	29.4	24.66	10.65
Common Stock	0.02	0.02	0.02	0	0	0.01
Additional Paid-in Capital	1,257	1,234	1,173	21.43	11.38	4.9
Accumulated Other Comprehensive Income	0.01	0.06	-0.08	-0.77	-	-
Retained Earnings	-1,125	-947.22	-703.43	-467.51	-336.61	-99.29
Total Common Shareholders' Equity	132.16	287.06	469.08	-446.85	-325.22	-94.38
Minority Interest	-	-	-	843.69	729.86	281.68
Shareholders' Equity	132.16	287.06	469.08	396.84	404.64	187.3
Total Liabilities & Equity	177.83	316.97	496.2	426.23	429.3	197.95
Total Debt	20.09	1.85	5.23	8.44	2.05	2.05
Net Cash (Debt)	151.44	305.73	448.75	363.44	407.2	189.93
Net Cash Growth	-50.47%	-31.87%	23.47%	-10.75%	114.39%	-
Net Cash Per Share	0.94	1.92	6.90	13.36	18.60	14.61
Book Value	132.16	287.06	469.08	-446.85	-325.22	-94.38
Book Value Per Share	0.82	1.80	7.21	-16.42	-14.85	-7.26
Tangible Book Value	132.16	287.06	469.08	-446.85	-325.22	-94.38
Tangible Book Value Per Share	0.82	1.80	7.21	-16.42	-14.85	-7.26

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q